NCT03858920View on ClinicalTrials.gov

The Liver in the World Trade Center Health Program General Responder Cohort and Controls

CompletedOBSERVATIONAL
Enrollment

340

Participants

Timeline

Start Date

May 8, 2018

Primary Completion Date

June 11, 2021

Study Completion Date

June 11, 2021

Conditions
Steatosis of LiverNASH - Nonalcoholic Steatohepatitis
Interventions
DEVICE

Fibroscan of Liver

A non-invasive diagnostic device used to measure liver scarring

PROCEDURE

Low-dose non-contrast CT

CT scan as part of routine research care

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT03858920 - The Liver in the World Trade Center Health Program General Responder Cohort and Controls | Biotech Hunter | Biotech Hunter